IN THE 2023-2024 SEASON

map gihsn home

Download here sites description.


Implementing Partners


partners senegal

Senegal, Dakar

Institut Pasteur of Dakar (IPD)

Since 2021-2022

The Institut Pasteur of Dakar Foundation (IPD) is a non-profit association of public utility, concerned with promoting public health and well-being in West Africa. Since its founding in 1896 by one of Louis PASTEUR’s disciples, Émile Marchoux, the IPD has been at the forefront of the fight against infectious diseases. Since 2009, the Institut Pasteur de Dakar has been a Senegalese foundation, jointly managed by the government of Senegal and the Institut Pasteur (Paris).

https://www.pasteur.sn/en (in english)

Ndongo DIA, Main Investigator

• Hôpital Albert Royer Dakar, CHU FANN
• Hôpital Général Idrissa Pouye de Grand Yoff
• Hôpital d’enfants de Diamniadio (HED)

partners ivorycoast

Côte d’Ivoire, Abidjan

National Institute of Public Hygiene

Since 2017-2018

The national institute is a public health institution whose mission is the control of infectious diseases. As such, it includes an epidemiological surveillance unit that conducts research on influenza.

http://www.inhp.ci/ (in french)

Daouda COULIBALY, Main Investigator

• University Teaching Hospital of ANGRE
• Regional Hospital of Korhogo
• Regional Hospital of San Pedro
• Regional Hospital of Man
• University Teaching Hospital of Bouaké (Bouaké City, Gbêkê Region)
• General Hospital of Agnibilekrou (Agnibilékro City, Indénié-Djuablin Region)
• Pediatric clinic of the University Teaching Hospital of Treichville (Abidjan)

partners kenya

Kenya, Nairobi

Kenya Medical Research Institute (KEMRI) and US Centers for Disease Control and Prevention (CDC)

Since 2017-2018

Kenya has conducted surveillance for influenza since 2006. Published data from these surveillance activities have shown a substantial burden of influenza, especially among children aged less than five years.

The GIHSN study is conducted using the existing health and demographic surveillance system (HDSS) in Western Kenya to estimate the incidence of influenza- and respiratory syncytial virus (RSV) – associated hospitalizations, and to quantify the distribution of the different influenza strains circulating in Kenya.

Data collected from this study will help bridge the gap on the burden of disease data in Kenya, particularly among the elderly as recently requested by the Kenya National Immunization Technical Advisory Group.

https://www.kemri.org/ (in english)

Dr Nancy A. OTIENO, Main Investigator

• Coast Provincial General Hospital (Mombasa City, Mombasa County)
• Nyeri Provincial General Hospital (Nyeri City, Nyeri County)
• Kenyatta National Hospital (Nairobi City, Nairobi County)
• Nakuru County Referral Hospital (Nakuru City, Nakuru County)
• Kakamega County Referral Hospital (Kakamega City, Kakamega County)
• Siaya County Referral Hospital (Siaya City, Siaya County)
• Marsabit County Referral Hospital (Marsabit City, Marsabit County)

partners southafrica

South Africa, Johannesburg

Respiratory and Meningeal Pathogens Research Unit

Since 2016-2017

RMPRU is a research Unit focused on the epidemiology, transmission, prevention and diagnosis of vaccine preventable diseases. RMPRU forms part of and is administered by the Wits Health Consortium, a wholly owned subsidiary of the University of the Witwatersrand.

RMPRU was established in 1997, with an original research mandate to investigate pneumococcal diseases at the molecular, epidemiological, clinical and pharmacological levels. Over time, the Unit has evolved to include investigating the clinical and molecular epidemiology of other bacteria and respiratory viruses that are associated with pneumonia and meningitis. Also, the Unit has established itself to be a premier clinical trial facility for vaccine and training platforms for post-graduate students.

The Unit has undertaken pivotal studies on pneumococcal conjugate vaccine, which have helped inform the utilisation of these vaccines in low-to-middle income countries. Also, the pneumococcal vaccine studies have helped inform the interaction of pneumococcus in relation to respiratory viruses and tuberculosis associated acute community acquired pneumonia. More recently, the Unit has further evolved to focus specifically on the epidemiology and prevention of infections during the neonatal period, including programs aimed at vaccinating pregnant women to confer passive immunity and protect infants during their first few months of life. These include studies on the influenza vaccines, GBS conjugate vaccine, pertussis vaccine and RSV vaccines.

Vicky Baillie, Main Investigator

• Chris Hani Baragwanath Academic Hospital

Uganda, Makerere

Uganda, Makerere

Makerere University Walter Reed Project

Since 2023 – 2024

The Makerere University Walter Reed Project (MUWRP), a project of the U.S. Military HIV Research Programme (MHRP), began offering safe male circumcision (SMC) as a pilot in 2009 in Kayunga District.
Makerere University Walter Reed Project (MUWRP) started its hospital-based sentinel surveillance activities for influenza and other respiratory viruses through its emerging infectious diseases program (EIDP) in 2008. Since then, MUWRP, has sustained these efforts, screening adenoviruses, respiratory syncytial viruses, human Boca viruses, human metapneumoviruses, para influenza viruses (1-4) and corona viruses including SARS-CoV-2. These surveillance efforts are implemented in collaboration with Uganda’s National Influenza Center (NIC).

www.muwrp.org (in English)

Prof. Denis Karuhize Byarugaba, Main Investigator

• Kayunga Regional Referral Hospital (Central Uganda)
• St Marys Lacor Hospital (Northern Uganda)
• Bwera Hospital (Western Uganda on border with the Democratic Republic of Congo
• Soroti Regional Referral Hospital (Eastern Uganda)


Argentina, Buenos Aires

The National Reference Laboratory for Influenza and other respiratory viruses

From 2017-2018 to 2018-2019

Since 1996 the National Reference Laboratory/WHO National Influenza Centre (NIC) of Argentina serves as a central repository for acute respiratory illness surveillance data.

The central hospital of the study is a health institution, where activities of prevention, treatment, diagnosis and rehabilitation are conducted, as well as teaching and research activities.

The identification of influenza and other respiratory viruses is conducted at the Respiratory Virus Laboratory, Virology Department, including the influenza subtyping, determination of the influenza B lineages and influenza A and B genomic characterization according to the protocol of a real time platform validated by the US Center for Disease Control and Prevention (CDC).

• Pr Elsa BAUMEISTER, Main Investigator & Project Director
• Pr Graciela CABRAL, Co-Investigator & Project Coordinator

National Hospital “Prof Alejandro Posadas” (Villa Sarmiento City, Buenos Aires Province)

Brazil, Curitiba

Hospital Pequeno Principe

Since 2018-2019

Pequeno Principe Hospital is a philanthropic institution, being a reference in pediatrics in the country.

It has performed influenza hospital-based surveillance since 2010, being a sentinel reference to cases of severe acute respiratory infection (SARI) for pediatric patients from Curitiba and other metropolitan region municipalities.

The hospital has a Department of Epidemiology and Infection Control that performs this surveillance. This department has participated in the GIHSN project – 2018- 2019 season and 2019-2020.

http://pequenoprincipe.org.br/ (in english and portuguese)

• Pr Sonia M. RABONI, Main Investigator
• Heloisa I. G. GIAMBERARDINO, Co-Investigator

Hospital Pequeno Principe (Curitiba City, Paraná State)

partners usa

United States of America, New York City

Icahn School of Medicine at Mount Sinai

Since 2021-2022

The Icahn School of Medicine at Mount Sinai is an international leader in medical and scientific training, biomedical research, and patient care. It is the medical school for the Mount Sinai Health System, which includes eight hospital campuses, and has more than 5,000 faculty and nearly 2,000 students, residents and fellows. Our unwavering pursuit of intellectual exchange, breakthrough research, and multidisciplinary teamwork propels us ever forward in biomedical discoveries and advances. We pursue ideas that often challenge conventional wisdom to revolutionize the practice of medicine and produce dramatically better outcomes for patients. We make big, bold bets by investing in radical free thinkers and technology at the cutting edge.

https://icahn.mssm.edu/ (in english)

Dr. Viviana SIMON, Main Investigator
Dr. Harm VAN BAKEL, Co-Investigator
Dr. Mia Emilia SORDILLO, Co-Investigator

• Mount Sinai Morningside
• Mount Sinai West
• Mount Sinai Brooklyn
• Mount Sinai Queens
• Mount Sinai Beth Israel
• The Mount Sinai Hospital

partners canada

Canada, Halifax

Canadian Center for Vaccinology

Since 2017-2018

The Canadian Center for Vaccinology (CCfV) is a multidisciplinary vaccinology research centre of Dalhousie University developed with funding from the Canada Foundation for Innovation, which brings together investigators from adult and pediatric infectious diseases, internal medicine, geriatrics, health law and bioethics, public health, nursing, pharmacy, epidemiology, health outcomes and health economics. CCfV is the lead institution and coordinating center for the Canadian Immunization Research Network. The SOS Network is coordinated by the Canadian Center for Vaccinology in Halifax, Nova Scotia.

https://centerforvaccinology.ca/ (in english)

• Dr Shelly A. McNEIL, Main Investigator
• Dr Melissa K. ANDREW, Co-Investigator

• Dartmouth General Hospital
• QEII Health Sciences Centre, Halifax NS

partners mexico

Mexico, Mexico City

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

From 2015-2016 to 2020-2021

The Ministry of Health Coordination Center of the National Institutes of Health and High Speciality Hospital (CCINSHAE)’s mission is to promote the highest level of scientific knowledge and to develop, maintain, and renew scientific human and physical resources that will ensure the Nation’s capability to prevent disease, enhance health and reduce illness and disability.

The Mexico National Institutes of Health and High Specialty Hospitals Surveillance Network integrate 12 National Health Institutions and Hospitals to ensure a wide geographic representation of the north, central and south areas of the country. Its purpose is the timely identification and estimation of the incidence of severe illness (hospitalization) and the description of the clinical characteristics caused by influenza and other respiratory viruses, as well as new and emerging infectious treats to ultimately protect and improve the health of the individual and the allocation of economic resources.

https://www.incmnsz.mx/opencms/ (in spanish)

• Dr Guillermo M. RUIZ-PALACIOS, Main Investigator
• María de LOURDES GUERRERO, Co-Investigator

• Instituto Nacional de Ciencias médicas y Nutrición Salvador Zubirán (Mexico City)
• Instituto Nacional de Enfermedades Respiratorias (Mexico City)
• Instituto Nacional de pediatría (Mexico City)
• Hospital Infantil de México (Mexico City)
• Hospital General Dr. Manuel Gea González (Mexico City)
• Hospital Central Dr. Ignacio Morones Prieto (San Luis Potosí City, San Luis Potosí State)

partners peru

Peru, Lima

Tropical Medicine Institute Daniel A. Carrion, San Marcos University, Lima – Peru and Centro de Investigaciones Tecnológicas, Biomédica y Medioambientales

Since 2016-2017

The Tropical Medicine Institute Daniel Carrion´s mision is to promote a highest level of scientific knolewdge in Tropical Infectious Diseases to contribute in the health care of the peruvian population. This Tropical Institute (IMT DAC in Spanish)works closely with the CITBM under a collaborative agreementincluding associate business and international research activities.

CITBM is the first Center of Excellence in Peru dedicated to the integration of science, development and technological innovation. CITBM is collaborating in multiple national and multinational biomedical, technology and innovation projects, including the development of rapid diagnostic tests and vaccines for infectious tropical diseases as malaria, leptospirosis, leishmaniasis and meningeal tuberculosis. Additionally, it leads the international consortium MDRTBNet (aERANet Lac initiative), with reference institutes of tuberculosis in Germany, Spain, France, Brazil and Italy.

http://citbm.unmsm.edu.pe/ (in spanish)

Dr Víctor A. LAGUNA TORRES, Main Investigator

• Hospital Santa Rosa Piura. Ministry of Health, Peru
• Carlos Alberto Seguin HNCASE, Social Security System Arequipa (EsSalud)
• Clinica Internacional, Two sites San Borja and Lima, Lima Peru
• Hospital Nacional Daniel Alcides Carrion


partners china Fudan

China, Shanghai

Fudan University

From 2016-2017 to 2021-2022

The study team is composed by the School of Public Health, Fudan University (SPH), Soochow University Affiliated Children’s Hospital (SCH) and Suzhou Center for Disease Control and Prevention (CDC).

All three institutions are well coordinated since foundation by US CDC in March 2011.
Fudan University is a comprehensive research university in China. As one of the first participants in the 211 and 985 projects. Fudan has 28 schools and 11 affiliated hospitals.

Since Mar 2011, founded by US CDC, the influenza surveillance system was established in Soochow University Affiliated Children’s Hospital (SCH). The surveillance includes influenza-like illness (ILI) and severe acute respiratory infection (SARI) patients.

SCH is a comprehensive tertiary hospital for children, one of the national influenza monitoring network hospitals, integrated with medical treatment, teaching, research and preventive health care.

http://shmc.fudan.edu.cn/eng (in english and chinese)

Dr Tao ZHANG, Main Investigator & Coordinator

Children’s Hospital of Soochow University (Soochow City, Jiangsu Province)

partners india

India, Srinagar

Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Department of Internal and Pulmonary Medicine

From 2015-2016 to 2022-2023

The SKIMS is engaged to provide high quality patient care, academic courses and need-based biomedical research to provide better patient care.

The institute has been one of the sites of the CDC,USA sponsored Multisite Surveillance for Influenza across India that has documented the patterns of influenza circulation in India.

http://skimsmc.edu.in/ (in english)

Dr Parvaiz KOUL, Main Investigator

Sher-i-Kashmir Institute of Medical Sciences SKIMS (Srinagar City, Jammu & Cashmir Territory)

partners nepal

Nepal, Patan

Patan Academy of Health Sciences

From 2019-2020 to 2022-2023

Patan Academy of Health Sciences (PAHS) is a non-profit, public, health science university established with an act of parliament in 2008. The central rationale for the establishment of PAHS was to contribute to the reduction of disparity in the health status among rural, urban, and disadvantaged populations in Nepal.

The site is a collaborating Oxford vaccine research group and implementing influenza surveillance project supported by US Centers for Disease Control and Prevention since 2009.

Until 2009, influenza-related surveillance work were patchy and has not had systematic effort. To systematize and strengthen influenza surveillance activities, PAHS participated in CDC influenza call and received a grant in 2009.

After the establishment of Nepal National Influenza Center in 2010, national health system started testing influenza sample within the country. Since then, Patan Academy started Influenza surveillance as one of the sentinel sites in Nepal under NIC.

Since 2011 Patan hospital sentinel sites have been collecting ILI epidemiological data and sample regularly on weekly basis.

https://www.pahs.edu.np/ (in english)

Kedar P. BARAL, Main Investigator

• Patan Hospital

partners nepal

Pakistan, Islamabad

National institute of health lslamabad Pakistan

Since 2022-2023

National Institutes of Health is one of the most prestigious institutions of the country involved in multi-disciplinary public health related activities like diagnostic services, research and production of various vaccines for over 40 years.

The idea of establishing a National Health Center (NHC) was conceived in early 1960’s, which started functioning in 1965 at Islamabad. Directorate of Nutrition Survey and some other health related research organizations were shifted to NHC. Later on, all these independently working departments were integrated and designated as National Health Laboratories (NHL – Islamabad).

This organization was given the status of an autonomous organization as National Institutes of Health (NIH) under the Ministry of Health (MoH) through a presidential ordinance XLIII of 1980, to facilitate international and regional collaboration, seek technical assistance and participate in global disease control programs more effectively.

https://www.nih.org.pk/ (in English)

•Nazish Badar, Main Investigator
•Dr Muhammad Salman, Main Investigator

• Abbas Institute of Medical sciences, Muzafarabad AJK
• PHQ hospital Gilgit Baltistan
• Allied Hospital Faisalabad Punjab
• Nishter medical university Multan Punjab
• Civil Hospital Karachi Sindh
• Bolan Medical complex Quetta, Baluchistan
• Saidu Sharif Hospital Swat, KPK
• Pakistan Institute of Medical Sciences, Islamabad, Pakistan


 partners france lyon

France, Lyon

Edouard Herriot Hospital, Department of Hygiene, Epidemiology and Prevention

From 2017-2018 to 2019-2020

Surveillance of nosocomial influenza was set-up in Edouard Herriot hospital in 2004 to estimate the risk of hospital acquired-ILI for hospitalized patients in short-stay units, and to identify determinants associated with nosocomial Influenza infection. Determinants from the community (influenza incidence, vaccine coverage, etc.) and from the hospital (underlying diseases, two-bed rooms, vaccine coverage among HCW, etc.) are explored to describe and initiate preventive measures to avoid hospital outbreak of influenza.

Since 2012 the hospital is involved into the FluVac study. This is a case-control prospective study coordinated by the REIVAC (Réseau national d’investigation clinique en vaccinologie). The main objective of this study is to assess the effectiveness of influenza vaccine in hospitalized patients with laboratory-confirmed influenza.

Pr Philippe VANHEMS, Main Investigator

Edouard Herriot Hospital (Lyon City)

partners france paris

France, Paris

I-REIVAC network – Inserm

From 2019-2020 to 2021-2022

5 universitary hospitals, all members of I-REIVAC network, are involved in the project in 2019-2020.

The I-REIVAC coordination team manage the monitoring of data in connecting with the local teams of each site to correct the errors, incoherencies or missing values within the database.

https://www.inserm.fr/ (in french and english)

• Pr Odile LAUNAY, Main Investigator
• Dr Can L. LUONG, Co-Investigator
• Zineb LESIEUR, Co-Investigator

• Hôpital Cochin (Paris City)
• Hôpital Bichat (Paris City)
• Hospices Civils de Lyon (Lyon City)
• Centre Hospitalier Universitaire de Montpellier (Montpellier City)
• Centre Hospitalier Universitaire de Rennes (Rennes City)

partners romania

Romania, Bucharest

The National Institute for Infectious Diseases “Prof. Dr. Matei Bals”

Since 2016-2017

The National Institute for Infectious Diseases “Prof. Dr. Matei Bals” is the excellence center in Romania for prevention, management and research in area of infectious diseases. As a research center, the hospital has extensive experience in conducting clinical trials in the field of infectious diseases having a dedicated and accredited (FDA) clinical trials center. Vaccine trials were routinely conducted in National Institute of Infectious Diseases “Prof. Dr. Matei Bals” Bucharest (flu, pneumococcal)Severe influenza cases, both in adult and pediatric population are managed in the Institute.

The Institute is also part in the national influenza surveillance system (Romania has a national sentinel type surveillance system for influenza).A dedicated hospital epidemiology unit contributes to the national influenza surveillance program.

Anca DRAGANESCU, Main Investigator

National Institute for Infectious Diseases “Prof. Dr. Matei Bals” (Bucharest City, Bucharest Municipality)

partners russia moscow

Russia, Moscow

FSBI National Center of Epidemiology and Microbiology by N.F.Gamaleya

Since 2012-2013

D.I. Ivanovsky Institute of Virology is one of the first-rate research organizations in the field of ecology, epidemiology, molecular biology, and molecular virology. Its mission is fundamental researching of virology, development and improvement of diagnostic methods and assessment of new antivirals against highly infectious and social diseases. Institute has been involved in influenza surveillance since 1959 both in Russia (USSR) and WHO. Since 2014 Institute had became a part of FSBI “N.F. Gamaleya FRCEM”.

https://gamaleya.org/en/ (in english and russian)

Elena BURTSEVA, Main Investigator

Clinical Hospital for Infectious Diseases n°1 (Moscow City, Central Federal District)

partners russia stpetersburg

Russia, St-Petersburg

Smorodintsev Research Institute of Influenza

Since 2012-2013

RII is a leading institution in the field of influenza and ARI surveillance in Russia.

RII incorporates Federal Influenza and ARI Centre and WHO National Influenza Centre, successfully operating both on the national and global levels as an integral part of WHO global influenza surveillance and response system.

https://www.influenza.spb.ru/en/ (in english and russian)

Daria Danilenko, Main Investigator

• Infectious Clinical City Hospital #1 (Novosibirsk) (code #9)
• Children’s Clinical City Hospital #3 (Novosibirsk) (code #8)
• Children’s Clinical City Hospital #6 (Novosibirsk) (code #7)
• Children’s Multidisciplinary Hospital # 4 named after Saint Olga (St.- Petersburg) (code # 3)
• Children’s Infectious Multidisciplinary Hospital # 5 named after N.F. Filatov (St.-Petersburg) (code # 2)
• Clinical Infectious Diseases Hospital named after S.P. Botkin, (St.- Petersburg) (code #1)

partners serbia

Serbia, Novi Sad

Institute of Public Health of Vojvodina

From 2017-2018 to 2019-2020

The Institute of public health (IPH) of Vojvodina have significant scientific and practical experience in the field of influenza and immunization that has been acquired in numerous studies. The IPH of Vojvodina is the leading state Institution for the communicable diseases surveillance (including influenza) that are envisaged for compulsory reporting in Vojvodina.

The World Health Organization (WHO) as the National Influenza Centre (NIC) has recognized the IPH of Vojvodina, Centre of virology, since 1953. NIC is part of the WHO Global Influenza Surveillance Network, with the principal task of continuous virologic surveillance of influenza virus activity in population of Vojvodina.

http://www.izjzv.org.rs/ (in serbian and english)

• Dr Snežana MEDIC, Main Investigator & Project Coordinator
• Dr Mioljub RISTIC, Co-Investigator & Province Coordinator

• Institute of Pulmonary Diseases of Vojvodina (Sremska Kamenica City, Autonomous Province of Vojvodina)
• Clinical Center of Vojvodina (Novi Sad City, Autonomous Province of Vojvodina)
• Institute for Health Care of Children and Youth of Vojvodina (Novi Sad City, Autonomous Province of Vojvodina)

partners spain

Spain, Valencia


Since 2012-2013

The Foundation for the Promotion of Health and Biomedical Research of Valencia Region, FISABIO, is a non-profit scientific and healthcare entity, whose primary purpose is to encourage, to promote and to develop scientific and technical health and biomedical research in Valencia Region.

FISABIO integrates and manages the Health Research Map of the Centre for Public Health Research, Dr. Peset University Hospital Foundation, Alicante University General Hospital Foundation, Elche University General Hospital Foundation, and the Mediterranean Ophthalmological Foundation. In addition, FISABIO assumes the scientific activity of other 18 Health Departments.

http://fisabio.san.gva.es/ (in english, spanish and catalan)

Alejandro Orrico Sanchez, Main Investigator

• Hospital General de Castellón (Castellón)
• Hospital Universitario y Politécnico La Fe (Valencia)
• Hospital General Universitario de Valencia (Valencia)
• Hospital Universitario Doctor Peset (Valencia)
• Hospital Marina Baixa (Alicante)

partners lebanon

Lebanon, Beirut

American University of Beirut Medical Center

Since 2018-2019

Infectious diseases remain among the leading causes of morbidity and mortality in the Middle East, with diseases such as pneumonia, gastroenteritis, malaria, and tuberculosis presenting a major burden in our region.

The Center for Infectious Diseases Research (CIDR) at the American University of Beirut Medical Center (AUBMC) promotes research in basic, translational, and clinical aspects of infectious diseases.

The aim of the CIDR laboratory is to function as a national and regional reference laboratory with emphasis on the diagnosis of endemic and epidemic infectious diseases relevant to our region.

https://www.aubmc.org.lb/pages/home.aspx (in english)

Dr Ghassan DBAIBO, Main Investigator

• Beqaa Hospital (Taalabaya City, Bekaa region, Zahleh district)
• Rafic Hariri University Hospital (Beirut City)
• New Mazloum Hospital (Tripoli City, North Lebanon region, Tripoli district)
• Keserwan Medical Center KMC (Jounieh City, Mount Lebanon region, Keserwan district)
• American University of Beirut Medical Center (Beirut City)
• Hammoud Hospital University Medical Center

partners Türkiye

Türkiye, Eskisehir

Turkish Society of Internal Medicine

Since 2019-2020

Turkish Society of Internal Medicine (TSIM) was founded in 1995 as a non-profit organization and since then the Society has grown fast and reached over 1300 members currently.

The Society has a mission to be leader in the training and continuing medical education of internal medicine specialists and subspecialists; and in the delivery of high-quality patient care.

Aligned with this mission, one of the goals of the Society is to support scientific research projects in the field of internal medicine and to mediate a respectful relationship between the Society and the public, the academia and the industry.

http://www.tihud.org.tr/ (in turkish)

• Dr Serhat UNAL, Main Investigator
• Dr Mine DURUSU TANRIOVER, Co-Investigator and Site Coordinator

• Ministry of Health, Ankara Research and Training Hospital
• Ankara University Faculty of Medicine, Children’s Hospital
• Hacettepe University Faculty of Medicine, Adult Hospital
• Ankara Bilkent City Hospital

clinic Barcelona

Spain, Barcelona

Hospital Clinic de Barcelona

Since 2023 – 2024

With over 100 years of history, the Hospital Clínic de Barcelona is a leading public healthcare provider in the city of Barcelona, Catalonia and the world, clearly committed to excellence in its three main areas of action: healthcare, research and teaching.
Hospital Clinic has been a sentinel hospital of the influenza surveillance network in hospitalized patients in Northeastern Spain since 2009. After the COVID-19 pandemic, surveillance was extended to the rest of respiratory viruses. A multidisciplinary team including hospital epidemiologists and nurses coordinate the program performance and data management of all cases, hand in hand with the laboratory professionals, the core of all sample processing and analysis.

https://www.clinicbarcelona.org/en (in english)

Miguel J. Martinez, Main Investigator

• Hospital Clinic de Barcelona

Poland, Warsaw

Poland, Warsaw

National Institute of Tuberculosis and Lung Diseases

Since 2023 – 2024

National Institute of Tuberculosis and Lung Diseases in Warsaw is a leading Polish research and clinical centre. It has long-term experience in the research and implementation of new technologies and therapies in the domain of lung diseases with main focus on COPD, SDB, interstitial lung diseases, and lung cancer. Due to its key clinical and scientific position in respiratory medicine in Poland, the institute serves as the national reference pulmonary clinical centre. The institute established, e.g., as first in Poland, the long-term oxygen therapy centre in 1986 and the non-invasive ventilation centre in 1996 to treat chronic respiratory failure. In 1988, the sleep laboratory was developed as a first in the country. These facilities have served for a long time as a main teaching site for students and physicians interested in chronic respiratory failure and OSA.

https://www.igichp.edu.pl/ (in polish)

Joanna Chorostowska-Wynimko, Main Investigator

• National Institute of Tuberculosis and Lung Diseases
• University Clinical Hospital – Central Veteran Hospita
• Saint Family Specialized Hospital
• Pediatric Teaching Clinical Hospital

Ukraine, Kiyv

Ukraine, Kiyv

SI Kyiv City Center for Diseases Control and Prevention of the Ministry of Health of Ukraine

Since 2023 – 2024

The Center for Disease Control and Prevention (CDC) established an office in Ukraine in 2010 to strengthen the capacity of the government and partners to prevent, detect, and respond to emerging global public health threats. CDC works with the Ukrainian Ministry of Health (MOH), the Public Health Center of Ukraine (UPHC), and other local and international partners to achieve HIV epidemic control. In addition, CDC supports Ukraine in strengthening laboratory, surveillance, and workforce capacity to combat disease outbreaks. CDC also supports Ukraine’s COVID-19 response.

Alla Mironenko, Main Investigator

• Children clinical hospital #9
• Kyiv city children infections hospital
• Khmelnitsky city infections hospital
• Dnipro city clinical hospital
• Kyiv city clinical hospital


New Zealand, Wallaceville

New Zealand, Wallaceville

Institute of Environmental Science and Research

Since 2023 – 2024

ESR (Institute of Environmental Science and Research) is New Zealand’s Crown Research Institute specialising in science for communities. ESR uses world-leading science to safeguard our health, keep our communities safer, protect our food-based economy, and improve the health of our water and natural environment.
ERS identifies infectious diseases and we strengthen New Zealand’s pandemic and infectious disease preparedness and contribution to global pandemic readiness.

https://www.esr.cri.nz/ (in English)

Professor Sue Huang, Main Investigator

• Auckland City hospital and associated Starship Children’s Hospital
• Middlemore hospital and associated KidsFirst Children’s hospital

18 Replies to “Contributing sites”

  1. fuck tthighereduhryyy.UNo17WIvasc

  2. strelkaproject.com
    Wang의 가족의 세단 의자가 Fang의 가족을 천천히 지나갔습니다.

  3. lfchungary.com
    Tang Yin은 절을하고 “왕자는 천세입니다. “라고 외쳤습니다.

  4. sm-slot.com
    “신고를 받고 바로 류씨를 찾으러 왔어요. 류씨는 민가에 있는데…”

  5. Valuable info. Fortunate me I discovered your website unintentionally,
    and I am stunned why this coincidence did not happened earlier!

    I bookmarked it.

  6. I constantly spent my half an hour to read this web site’s posts everyday along with a mug of coffee.

    Feel free to visit my webpage; เครดิต ฟรี 188 บาท 2022

  7. pragmatic-ko.com
    그게 다야, 저속한 사람들을 다루려면 저속한 사람들의 방법을 사용해야합니다.관리들은 Fang Jifan을 바라 볼 수 없었습니다. 이 남자는 … 까마귀 입을 가지고 있습니다.

  8. sm-slot.com
    Xing Wang Zhu Youzhu의 기질은 여전히 부드럽고 정직합니다.

  9. yangsfitness.com
    그러나 Hongzhi 황제의 때리는 것은 매우 단단했고 그의 뺨은 약간 부어있었습니다.

  10. I’ll immediately clutch your rss as I can not to find your e-mail subscription hyperlink or newsletter service.
    Do you’ve any? Please allow me understand in order that I could
    subscribe. Thanks.

    Feel free to visit my blog – เครดิตฟรี จีคลับ

  11. lfchungary.com
    “Xu 형제는 …”홍지 황제는 놀랐습니다.

  12. pragmatic-ko.com
    이 죽은 그가 막 작은 내시에게 사라고 명령한 것이었다.

  13. pragmatic-ko.com
    Zhu Houzhao는 화가 나서 궁전으로 돌아 왔고 Liu Jin은 조심스럽게 그를 기다렸습니다.

  14. sm-casino1.com
    드디어 마지막 요리가 나왔습니다.

  15. It’s impressive that you are getting ideas from this article as well as from our argument made at this place.

    my homepage … ขายไวน์

  16. lfchungary.com
    Xie Qian은 서둘러 “내시 Xiao, 광동 수석 사절 문제 …”

  17. mikschai.com
    Liu Wenzhi는 30%를 유지하는 것으로 충분합니다.

Leave a Reply

Your email address will not be published.

You may use these <abbr title="HyperText Markup Language">HTML</abbr> tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Hi, How Can We Help You?